MSOE Library Home	Login My List - 0 Help
	Home   Search   My Account

Basic Advanced Power History

Search:  Author KeywordsBarcodeBib No.Call Number Keyword Search (Enter part of a call number -- use wildcards)General Keyword SearchKeyword Search of Contents NotesKeyword Search of Credits Notes (Enter word or words)Keyword Search of FormatKeyword Search of Item DescriptionKeyword Search of Publisher's NameName Keyword SearchPublication Date Keyword SearchSearch Part of an ISBN NumberSearch Part of an ISSN NumberSeries Title KeywordsSubject KeywordsTitle Keywords       Refine Search     > You're searching: Walter Schroeder Library, Milwaukee School of Engineering

Item Information   Holdings     Summary       More by this author     Carreyrou, John, author.     Subjects     Theranos (Firm) -- History.     Hematologic equipment industry -- United States.     Fraud -- United States     Browse Catalog     by author:      Carreyrou, John, author.       by title:      Bad blood : secrets ...         MARC Display

Bad blood : secrets and lies in a Silicon Valley Startup / John Carreyrou. by Carreyrou, John, author. Vintage Books, a division of Penguin Random House LLC, 2020. Subjects Theranos (Firm) -- History.   Hematologic equipment industry -- United States.   Fraud -- United States Description:  x, 341 pages, 8 unnumbered pages of plates : illustrations ; 21 cm Edition:  First Vintage Books Edition. Contents:  Prologue -- A purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- "Who is LTC Shoemaker?" -- Lighting a Fuisz -- Ian Gibbons -- Chiat\Day -- Going live -- Unicorn -- The grandson -- Fame -- The Hippocratic Oath -- The tip -- The ambush -- Trade secrets -- La mattanza -- Damage control -- The empress has no clothes. "The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"-- "The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"-- Form:  text txt unmediated n volume nc   Copy/Holding information Location Collection Call No. Status Due Date   Walter Schroeder Library Circulating Books HD9995.H423 U627 2020 Available   Add Copy to MyList Walter Schroeder Library Circulating Books HD9995.H423 U627 2020 .2 Available   Add Copy to MyList Walter Schroeder Library Circulating Books HD9995.H423 U627 2020 .3 Available   Add Copy to MyList Walter Schroeder Library Circulating Books HD9995.H423 U627 2020 .4 Checked out 08/21/2020 Add Copy to MyList Format: HTMLPlain textDelimited Subject:   Email to:

Horizon Information Portal 3.25_9885

© 2001-2013 SirsiDynix All rights reserved.